Atlas Trials

Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)

Clinical trial NCT05817942 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05817942
Sponsor
Alfasigma S.p.A.
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Ulcerative Colitis
Start date
2023-06-12
Primary completion
2027-12-01
Enrollment
509

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.